NASDAQ:AWH
Aspira Women's Health Inc. Stock News
$2.47
+0.320 (+14.88%)
At Close: May 31, 2024
Aspira Women's Health to Present at the A.G.P. Healthcare Showcase on May 21
08:00am, Thursday, 16'th May 2024
AUSTIN, Texas, May 16, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women's health company focused on the development o
Aspira Women's Health Inc. (AWH) Q1 2024 Earnings Call Transcript
11:50am, Wednesday, 15'th May 2024
Aspira Women's Health Inc. (NASDAQ:AWH ) Q1 2024 Results Conference Call May 15, 2024 8:30 AM ET Company Participants Nicole Sandford - CEO Sandy Milligan - President Torsten Hombeck - CFO Conference
Aspira (AWH) Reports Q1 Loss, Tops Revenue Estimates
09:40am, Wednesday, 15'th May 2024
Aspira (AWH) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.36. This compares to loss of $10.94 per share a year ago.
Aspira Women's Health Reports First Quarter 2024 Financial Results
07:30am, Wednesday, 15'th May 2024
Q1 2024 OvaSuite S M revenue of $2.2 million and volume of 5,829 units
UPDATE -- Aspira Women's Health to Announce First Quarter Earnings Results and Host a Conference Call on Wednesday, May 15
08:47am, Wednesday, 08'th May 2024
AUSTIN, Texas, May 08, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women's health company focused on the development o
Aspira Women's Health to Announce First Quarter Earnings Results and Host a Conference Call on Wednesday, May 15
08:00am, Wednesday, 08'th May 2024
AUSTIN, Texas, May 08, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women's health company focused on the development o
Aspira Women's Health Announces Anthem Blue Cross to Provide Coverage for OvaSuite(SM) in California
08:00am, Tuesday, 09'th Apr 2024
Coverage represents approximately 6 million lives, including commercial, Medicare Advantage, and Medicaid Coverage represents approximately 6 million lives, including commercial, Medicare Advantage, a
Aspira Women's Health Inc. (AWH) Q4 2023 Earnings Call Transcript
11:37am, Thursday, 28'th Mar 2024
Aspira Women's Health Inc. (AWH) Q4 2023 Earnings Call Transcript
Aspira Women's Health Reports Fourth Quarter and Full Year 2023 Financial Results
07:30am, Thursday, 28'th Mar 2024
2023 OvaSuite revenue of $9.2 million, an increase of 15% year-over-year 2023 OvaSuite volume of 23,990 units, an increase of 12% year-over-year Cash utilization declined in both the fourth quarter an
Aspira Women's Health to Present at the MedInvest Biotech & Pharma Investor Conference
08:00am, Thursday, 21'st Mar 2024
AUSTIN, Texas, March 21, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women's health company focused on the development
AUSTIN, Texas, March 11, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women's health company focused on the development
Aspira Women's Health to Present at The Cancer Advocacy Group of Louisiana's 3rd Annual NeauxCancer Conference
08:30am, Thursday, 22'nd Feb 2024
AUSTIN, Texas, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women's health company focused on the development
AUSTIN, Texas, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (“Aspira”) (Nasdaq: AWH), a bio-analytical based women's health company focused on the development of gynecologic diseas
AUSTIN, Texas, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical based women's health company focused on the development
Aspira Women's Health to Participate in Corporate Access Events During JP Morgan Healthcare Conference Week 2024
08:00am, Thursday, 14'th Dec 2023
AUSTIN, Texas, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical based women's health company focused on the developme